NCT07082296 (iCBT-Academia) is a NA clinical trial of iCBT-Academia in Emotional Well-being, sponsored by Joaquim Radua.

Who is sponsoring NCT07082296?

NCT07082296 is sponsored by Joaquim Radua.

What drugs are being tested in NCT07082296?

Interventions in NCT07082296: iCBT-Academia.

What condition does NCT07082296 study?

NCT07082296 studies Emotional Well-being.

Is NCT07082296 still recruiting?

NCT07082296 is currently completed. Last updated 24 March 2026.

Last reviewed 2026-03-24 · How we verify

NCT07082296: iCBT-Academia

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iCBT to Promote Emotional Well-being in University and Research Communities: Feasibility and Acceptability Study

Completed NA Last updated 24 March 2026

What this trial tests

NA trial testing iCBT-Academia in Emotional Well-being in 35 participants. Completed in 1 January 2026.

Timeline

11 July 2025

Primary endpoint
1 January 2026

1 January 2026

Quick facts

Lead sponsor	Joaquim Radua
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	11 July 2025
Primary completion	1 January 2026
Estimated completion	1 January 2026
Sites	1 location across Spain

Drugs / interventions tested

iCBT-Academia

Conditions studied

Emotional Well-being — all drugs for Emotional Well-being →

Sponsor

Joaquim Radua

Who can join

18 and older, any sex, with Emotional Well-being. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate a brief internet-based cognitive behavioral therapy (iCBT) program developed specifically for university students, researchers, and academic staff. People in academic settings often face high levels of pressure and may experience psychological difficulties such as anxiety or excessive worry. However, access to psychological support adapted to the academic context is frequently limited. This study investigates whether a short, self-guided online iCBT program can help promote emotional well-being in this population. The program is based on cognitive behavioral therapy principles and is designed to be completed in four weeks, with brief sessions four times per week that can be accessed on any device. Participants will complete questionnaires before and after the intervention to assess the feasibility, acceptability, and safety of the program, as well as changes in emotional well-being. The aim is to evaluate whether this digital intervention can serve as a useful, scalable tool to support emotional well-being in university and research environments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07082296 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Joaquim Radua
Last refreshed: 24 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07082296.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing